Table 6 Innate-like T cell subsets
Subset name | Markers and assays | Description | |
|---|---|---|---|
Human | Mouse | ||
MAIT cell (mucosal- associated invariant T cell) | CD3+, MR1-5OPRU tetramer+ In blood, CD3+, CD161+ and Vα7.2+ may suffice | CD3+, TCRβ+, MR1-5OPRU tetramer+ | T cells with an invariant TCRα chain paired with a TCRβ chain from a restricted repertoire The invariant TCRs recognize microbial riboflavin-derivative antigens presented by the non-polymorphic MHC class I-like protein MR1 |
Invariant natural killer T (iNKT) cell | CD3+, CD1d-aGalCer tetramer+ In blood, CD3+ and Vα24J18 (6B11)+ or Vα24+/Vβ11+ may suffice | CD3+, TCRβ+, CD1d-aGalCer tetramer+ | A subset of NKT cells with a limited TCR repertoire They recognize self and non-self lipid antigens in the context of CD1d |
γδ T cells | γδ TCR+ | γδ TCR+ | A lineage of lymphocytes defined by the expression of the TCRγδ antigen receptor |
Human blood γδ T cells | Most express Vγ9Vδ2 TCR, CD161+, NKG2A+, CCR5+ (and CD16+ after activation) Others are termed Vδ2− but are primarily Vδ1+ and are generally TIGIT+, CD31+, CD127+, CD62L+, CD49a−, CD101− and NKG2D+ Naive Vδ2− cells are CD27+, CD45RA Antigen-experienced effector cells are CD27−, CD45RA+, CXCR3low and IL-7R− | ND | ND |
Human intestinal γδ T cells | Most are Vδ2− and Vδ1+, mainly CD103+, CD38+, CD69+, CD101+, TIGIT+, CD5− and CD18− Of these cells, Vγ4+ cells uniquely selected on BTNL3–BTNL8 marked by NKp46+ and FcεR1γ+, whereas Vγ2+ or Vγ3+ cells are NKp46−, FcεR1γ− and CD31+ | ND | It has been proposed that these intestinal Vδ1+ cells be split by effector molecules into a cytolytic subset and an amphiregulin-expressing wound repair subset |
Human skin γδ T cells | Mostly Vδ1+, NKG2D+, CD69+, CXCR4+, CD44+, CD28− | ND | ND |
Mouse spleen and lymph node γδ T cells | ND | γδIFNγ cells: mainly make IFNγ CD27+, CD44+, CD45RB+, SCART1/2− and CCR6− Mostly TCRVγ1+ γδ17 cells: mainly make IL-17A CD44hi, CD27−, CD45RB−, SCART1/SCART2+ and CCR6+ They are mostly TCRVγ4+ γδNKT cells: a minor subset, make IL-4 NK1.1+, PLZF+ Mostly express Vγ1Vδ6.3 or Vγ1Vδ6.4 | Classified into three main types based on effector potential |
Mouse epidermis γδ T cells | ND | Mainly Vγ5Vδ1+ CD45RBhi, CD3hi and CD103+ | Mostly dendritic epidermal T cells (DETC) expressing a canonical Vγ5Vδ1 TCR |
Mouse dermis γδ T cells | ND | Mainly Vγ6Vδ1+ (with some Vγ4+ cells) CD44+, CD69+, CD103+, CCR6+, CD27− | ND |
Mouse uterus γδ T cells | ND | Mainly Vγ6Vδ1+ (with some Vγ4+ cells) CD44+, CD69+, CD3hi, PD-1+, CD27−, CD45RB−, CD103+, CCR6+ | ND |
Mouse intestinal intraepithelial lymphocyte (IEL) γδ T cells | ND | Mainly Vγ7+ TIGIT+, CD69+, CD122+, LAG3+, Thy1−, CD8αα+ (about 85%), Fcεr1γ+, CD3hi CD5low, CD45RB+ | ND |
CD8αα+ TCRαβ T cells | most CD8αα+TCRαβ T cells are HLA-DRhi | Thymic leukaemia (TL) antigen tetramer+ and CD8β− | Express a CD8αα homodimer instead of the more conventional CD8αβ heterodimer |
Double-negative (DN) T cells | TCR+, CD3+, CD4−, CD8αβ−, CD56− | TCR+, CD3+, CD4−, CD8αβ−, NK1.1− | Lack the conventional co-receptors CD8αβ and CD4 but do express either TCRαβ or TCRγδ |
Extrathymic double-positive (DP) T cells | TCR+, CD3+, CD4+, CD8 (CD8αα or CD8αβ)+ | TCR+, CD3+, CD4+, CD8 (αα or αβ)+ | Outside the thymus, DP T cells are a heterogenous population of cells that maintain expression of both conventional T cell co-receptors CD4 and CD8 (either CD8αα or CD8αβ) |